DK0724433T3 - Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje - Google Patents

Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje

Info

Publication number
DK0724433T3
DK0724433T3 DK94931369T DK94931369T DK0724433T3 DK 0724433 T3 DK0724433 T3 DK 0724433T3 DK 94931369 T DK94931369 T DK 94931369T DK 94931369 T DK94931369 T DK 94931369T DK 0724433 T3 DK0724433 T3 DK 0724433T3
Authority
DK
Denmark
Prior art keywords
fluidized bed
drying step
bed drying
preparing microspheres
microspheres
Prior art date
Application number
DK94931369T
Other languages
English (en)
Inventor
Jeffrey L Cleland
Andrew J Jones
Michael Frank Powell
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0724433T3 publication Critical patent/DK0724433T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94931369T 1993-10-22 1994-10-13 Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje DK0724433T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14225793A 1993-10-22 1993-10-22
US14331393A 1993-10-25 1993-10-25
PCT/US1994/011678 WO1995011009A1 (en) 1993-10-22 1994-10-13 Method for preparing microspheres comprising a fluidized bed drying step

Publications (1)

Publication Number Publication Date
DK0724433T3 true DK0724433T3 (da) 1999-08-30

Family

ID=26839915

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94931369T DK0724433T3 (da) 1993-10-22 1994-10-13 Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje

Country Status (9)

Country Link
EP (1) EP0724433B1 (da)
JP (1) JP3841309B2 (da)
AT (1) ATE175110T1 (da)
AU (1) AU8017494A (da)
CA (1) CA2172508C (da)
DE (1) DE69415684T2 (da)
DK (1) DK0724433T3 (da)
UY (1) UY23846A1 (da)
WO (1) WO1995011009A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589167A (en) * 1993-02-23 1996-12-31 Genentech, Inc. Excipient stabilization of polypeptides treated with organic solvents
DK0729357T3 (da) 1993-11-19 2005-06-06 Janssen Pharmaceutica Nv Mikroindkapslede 1,2-benzazoler
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
EP0765660A3 (en) * 1995-09-28 1998-09-23 Takeda Chemical Industries, Ltd. Microcapsules comprising 2-piperazinone-1-acetic acid compounds
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
EP0862419B2 (en) 1995-11-09 2010-11-17 Microbiological Research Authority Microencapsulated dna for vaccination and gene therapy
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres
DE69717263T2 (de) 1996-03-28 2003-07-24 Takeda Chemical Industries, Ltd. Zubereitung mit verzögerter freisetzung und deren herstellung
DK1210942T3 (da) * 1996-05-07 2007-07-23 Alkermes Inc Mikropartikler
US6645495B1 (en) * 1997-08-29 2003-11-11 Antigenics, Inc. Compositions of saponin adjuvants and excipients
AU1384199A (en) 1997-11-07 1999-05-31 Chiron Corporation Method for producing igf-1 sustained-release formulations
SE9801288D0 (sv) 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
AU1226901A (en) * 1999-10-22 2001-05-08 Amgen, Inc. Biodegradable microparticles with novel erythropoietin stimulating protein
EP1853228A4 (en) * 2005-03-01 2012-07-18 Sun Pharma Advanced Res Co Ltd METHOD FOR THE PRODUCTION OF MICROBALLS OR MICRO CAPSULES
US20170079962A1 (en) 2009-11-11 2017-03-23 Rapamycin Holdings, Llc Oral Rapamycin Preparation and Use for Stomatitus
US9486416B2 (en) 2009-12-22 2016-11-08 Evonik Corporation Emulsion-based process for preparing microparticles and workhead assembly for use with same
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
EP2739287B1 (en) * 2011-08-04 2017-07-05 Flexion Therapeutics, Inc. Corticosteroids for the treatment of joint pain
CA3206208A1 (en) 2013-12-31 2015-07-09 Rapamycin Holdings, Llc Oral rapamycin nanoparticle preparations and use
JPWO2023277051A1 (da) * 2021-06-30 2023-01-05

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IT1214629B (it) * 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
IL84167A (en) * 1986-10-24 1991-04-15 Southern Res Inst Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
JP2813630B2 (ja) * 1987-02-20 1998-10-22 ジェネンテク，インコーポレイテッド ヒト免疫不全ウイルスのエンベロープポリペプチドおよびその抗体
EP0279688B1 (en) * 1987-02-20 1997-04-16 Genentech, Inc. Methods and compositions for the use of HIV env polypeptides and antibodies thereto
FI101889B1 (fi) * 1988-08-24 1998-09-15 Allied Colloids Ltd Menetelmä partikkelikoostumuksen valmistamiseksi, joka sisältää polymeerimateriaalia sisältäviä partikkeleita
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
FR2658432B1 (fr) * 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation.
WO1992019263A1 (en) * 1991-04-24 1992-11-12 The United States Of America, As Represented By The Secretary Of The Army Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
FR2703927B1 (fr) * 1993-04-13 1995-07-13 Coletica Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une polyamine pour former en milieu aqueux une membrane au moins en surface de particules gélifiées.
ATE223702T1 (de) * 1993-10-22 2002-09-15 Genentech Inc Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
DK0724432T3 (da) * 1993-10-22 2003-01-27 Genentech Inc Fremgangsmåder og præparater til mikroindkapsling af antigener til brug som vacciner

Also Published As

Publication number Publication date
JPH09504026A (ja) 1997-04-22
JP3841309B2 (ja) 2006-11-01
AU8017494A (en) 1995-05-08
DE69415684T2 (de) 1999-06-10
WO1995011009A1 (en) 1995-04-27
ATE175110T1 (de) 1999-01-15
DE69415684D1 (de) 1999-02-11
UY23846A1 (es) 1995-03-28
EP0724433B1 (en) 1998-12-30
CA2172508C (en) 2005-08-23
EP0724433A1 (en) 1996-08-07
CA2172508A1 (en) 1995-04-27

Similar Documents

Publication Publication Date Title
DK0724433T3 (da) Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje
DE69107949D1 (de) MOS-gesteuerter Thyristor und Verfahren zu dessen Herstellung.
FI940487A0 (fi) Vianmääritysmenetelmä kehitysprosessia varten
MX26183A (es) Proceso para fabricar un estabilizador preformado de alta potencia, estabilizador preformado y composicion estabilizadora.
DE59201992D1 (de) Verfahren zum Verbrennen von Kohle in der zirkulierenden Wirbelschicht.
DK146489A (da) Fremgangsmaade til fremstilling af 2',3'-dideoxy-2',3'-didehydronucleosider
DE69119742D1 (de) Photographisches Entwicklungsverfahren, in dem ein Ascorbin-Säure-Derivat eingesetzt wird
DE59106464D1 (de) Verfahren zum Fixieren von Farbstoffen.
DK0417830T3 (da) Energibesparende fremgangsmåde til fremstilling af urea
NO176092C (no) Fremgangsmåte for omdanning av alifatiske C2 - C6-hydrocarboner til cycloalkaner
DE69021341D1 (de) Härtungsmittel, verfahren zu seiner herstellung und damit hergestellte härtbare zusammensetzung.
FI923099A (fi) Biomassa foer att producera virus/ virusantigen.
ES2182622A1 (es) Compuestos a base de compuestos de polialquil-1-oxa-diazaespirodecanos.
MX9200793A (es) Tetrahidropirinas y metodo para su preparacion.
DK0546350T3 (da) Fremgangsmåde til fremstilling af tørrede frugter
DE68911516D1 (de) Vergasungsverfahren.
DE58900561D1 (de) 2-aza-4-(alkoxycarbonyl)spiro-(4,5)decan-3-on.
DE69120773D1 (de) Ladungsträgeranordnung, Verfahren zu ihrer Herstellung und Verfahren zu ihrer Steuerung
NO982474L (no) FremgangsmÕte for fremstilling av 1-aryl-1-cyanocyklobutan-derivater
DK0570881T3 (da) Fremgangsmåde til fremstilling af støvfattige granulater
FI903088A0 (fi) Process foer framstaellning av straengsprutade skumkroppar.
HU9202929D0 (en) Substituted amino-propane derivatives, method for producing them and their utilization
DE69103046D1 (de) Heissklebeverfahren.
NO881565L (no) Stav, saerlig skistav.
FI915244A0 (fi) Biometallurgisk process i vilken biooxidation av mineralfoereningar utfoeres.